QQ客服 官方微博 反馈留言

	Overcoming multiple myeloma drug resistance in the era of cancer \'omics\'.
	Guang MHZ; McCann A; Bianchi G; Zhang L; Dowling P; Bazou D; O\'Gorman P; Anderson KC
刊名	Leuk Lymphoma
	2018
卷号	Vol.59 No.3页码:542-561
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1841823
专题	四川大学
作者单位	1.USA 2.Harvard Med Sch, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Dept Med Oncol, Boston, MA 3.Mater Misericordiae Univ Hosp, Dept Haematol, Dublin 7, Ireland 4.Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin, Ireland 5.Univ Coll Dublin, Coll Hlth & Agr Sci, UCD Sch Med, Dublin, Ireland 6.Sichuan Univ, West China Hosp, Dept Hematol, Chengdu, Sichuan, Peoples R China
推荐引用方式 GB/T 7714	Guang MHZ,McCann A,Bianchi G,et al. Overcoming multiple myeloma drug resistance in the era of cancer \'omics\'.[J]. Leuk Lymphoma,2018,Vol.59 No.3:542-561.
APA	Guang MHZ.,McCann A.,Bianchi G.,Zhang L.,Dowling P.,...&Anderson KC.(2018).Overcoming multiple myeloma drug resistance in the era of cancer \'omics\'..Leuk Lymphoma,Vol.59 No.3,542-561.
MLA	Guang MHZ,et al."Overcoming multiple myeloma drug resistance in the era of cancer \'omics\'.".Leuk Lymphoma Vol.59 No.3(2018):542-561.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。